A competing pharmaceutical company is suing SC’s Nephron over drugs it says the company sold without FDA approval, undercutting its own medication on the market.
2021 Webinar Series: Life Sciences with Nexsen Pruet - Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will f.